This morning (June 28), the ribbon-cutting ceremony for the official operation of Spectrum Biotechnology R&D Center was held. Gu Hongjian, member of the Party Working Committee and deputy director...
Recently, Jiangsu Puxin Biopharmaceutical Co., Ltd. (hereinafter referred to as "Puxin Biopharmaceutical") and Maoxing Biopharmaceutical Technology Co., Ltd. (hereinafter referred to as &quo...
Jiangsu Puxin Biopharmaceutical Co., Ltd. ("Puxin Bio" or "the Company") has continued to attract capital attention within two months after the completion of the Pre-A round of fin...
On May 11, the unveiling ceremony of the "Judges' Studio in the Park" of Wuzhong District People's Court was held in Suzhou (Taihu) Software Industrial Park. Dong Qihai, Party Secret...
Recently, Jiangsu Puxin Biopharmaceutical Co., Ltd. ("Puxin Bio" or "the Company") completed a Pre-A round of financing of nearly 100 million yuan. This round of financing was led ...
From November 13 to 14, 2021, the 2021 Third Annual Bioprocess Industry Summit was successfully held in Shanghai. With the theme of "Latecomers Arrive Faster, Great Things Will Come", many e...
On October 11-12, 2021, the BPID Biopharmaceutical Industry Development Conference and the 2021 Life and Health Industry Summit Forum were successfully concluded in Shanghai. The conference discussed ...
From October 13 to 16, 2021, the "First China (Suzhou) Taihu Pharmaceutical Innovation Conference" hosted by the Wuzhong District People's Government of Suzhou City and undertaken by the...
On August 14, 2021, Jiangsu Spectrum Biopharmaceutical Co., Ltd. (hereinafter referred to as "Spectrum Bio") and Promis Biotech Co., Ltd. (hereinafter referred to as "Promis") reac...
Cell and gene therapy technology is undoubtedly one of the most popular biotechnology fields at present, and is also regarded as the next generation of innovative therapies for disease treatment. In t...
400-900-1882 
info@hillgene.com 
English